Literature DB >> 7836408

Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface.

D H Allen1, P B Tracy.   

Abstract

The ability of intact peripheral blood monocytes to modulate factor V procoagulant activity was studied using electrophoretic and autoradiographic techniques coupled to functional assessment of cofactor activity. Incubation of plasma concentrations of factor V with monocytes (5 x 10(6)/ml) resulted in the time-dependent cleavage of the 330-kDa protein. Activation occurred via several high molecular mass intermediates (> or = 200 kDa) to yield peptides of 150, 140, 120, 94, 91, 82, and 80 kDa, which paralleled the expression of cofactor activity. The cleavage pattern observed differed from that obtained with either thrombin or factor Xa as an activator. The incubation time required to achieve full cofactor activity was dependent on the monocyte donor and ranged from 10 min to 1 h and was consistently slightly lower than that obtained with thrombin-activated factor Va. Cofactor activity was not diminished by additional incubation. The cofactor activity generated bound to the monocyte such that a competent prothrombinase complex was formed at the monocyte membrane surface. Furthermore, within 5 min of factor V addition to monocytes, near maximal cofactor activity (approximately 70%) was bound and expressed on the monocyte membrane. The proteolytic activity toward factor V was associated primarily with the monocyte membrane, as little proteolytic activity was released into the cell-free supernatant. Proteolytic activity was inhibited by diisopropyl fluorophosphate and phenylmethanesulfonyl fluoride. However, the inhibitor profile obtained with alpha 1-antiproteinase inhibitor, alpha 1-antichymotrypsin, and alpha 2-macroglobulin suggested membrane-bound forms of elastase and cathepsin G were mediating, in large part, the proteolysis observed. These data were confirmed using purified preparations of both proteases and a specific anti-human leukocyte elastase antibody. Thus, expression of these proteases at the monocyte surface may contribute to thrombin generation at extravascular tissue sites by catalyzing the activation of the essential cofactor, factor Va, which binds to the monocyte surface and supports the factor Xa-catalyzed activation of prothrombin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7836408     DOI: 10.1074/jbc.270.3.1408

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Endothelium-dependent relaxation induced by cathepsin G in porcine pulmonary arteries.

Authors:  E Glusa; C Adam
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study.

Authors:  Takuya Shiraishi; Shizukiyo Ishikawa; Kazuomi Kario; Kazunori Kayaba; Eiji Kajii
Journal:  J Clin Lab Anal       Date:  2017-02-13       Impact factor: 2.352

3.  Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation.

Authors:  J Plescia; D C Altieri
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes.

Authors:  Pam Massullo; Lawrence J Druhan; Bruce A Bunnell; Melissa G Hunter; John M Robinson; Clay B Marsh; Belinda R Avalos
Journal:  Blood       Date:  2005-01-18       Impact factor: 22.113

5.  The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.

Authors:  P Hof; I Mayr; R Huber; E Korzus; J Potempa; J Travis; J C Powers; W Bode
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

Review 6.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

7.  A novel notch protein, N2N, targeted by neutrophil elastase and implicated in hereditary neutropenia.

Authors:  Zhijun Duan; Feng-Qian Li; Jeremy Wechsler; Kimberly Meade-White; Kayleen Williams; Kathleen F Benson; Marshall Horwitz
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 8.  Remodeling the blood coagulation cascade.

Authors:  Maureane Hoffman
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

9.  Evolution of primary hemostasis in early vertebrates.

Authors:  Seongcheol Kim; Maira Carrillo; Vrinda Kulkarni; Pudur Jagadeeswaran
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

10.  Effective DNA inhibitors of cathepsin g by in vitro selection.

Authors:  Barbara Gatto; Elena Vianini; Lorena Lucatello; Claudia Sissi; Danilo Moltrasio; Rodolfo Pescador; Roberto Porta; Manlio Palumbo
Journal:  Int J Mol Sci       Date:  2008-06-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.